Sweden’s Sobi agrees to acquire CTI BioPharma for $1.7bn
The transaction, which has been unanimously approved by the Board of Directors of both the companies, is expected…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 May 23
The transaction, which has been unanimously approved by the Board of Directors of both the companies, is expected…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
11 May 23
The approval was based on two late-stage studies, which revealed significant improvement in calming agitated patients with Alzheimer's…
10 May 23
The consortium comprising Elliott Investment Management, an affiliate of Elliott Associates, along with healthcare investment firm Patient Square…
10 May 23
Founded in 2021, XinThera is aiming to develop small molecule drugs for the treatment of cancer and immunologic…
10 May 23
Innovative therapy shown to help promote healing and reduce the need for surgical debridements creating potential savings for…
09 May 23
The transaction includes BPS’ manufacturing facilities, along with around 1,700 employees working in Bloomington, Indiana and Halle, Germany,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 May 23
Mydcombi is a drug-device combination product that uses Eyenovia’s proprietary drug delivery device Optejet
08 May 23
The biotechnology company has entered negotiations with a major global pharmaceutical company, for the development and commercialisation of…
08 May 23
BRUKINSA is now the only new-generation BTK inhibitor in China to have been approved for the first-line treatment…
05 May 23
Under the terms of the agreement, Novocol Pharma will provide fill-finish and packaging for vaccines manufactured at Moderna’s…